No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs566099458 |
chr2:98544802-98544803 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs190766674 |
chr2:98544806-98544807 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs568074150 |
chr2:98544826-98544827 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs533537612 |
chr2:98544875-98544876 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs539476328 |
chr2:98545026-98545027 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs369944500 |
chr2:98545040-98545041 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs570167420 |
chr2:98545044-98545045 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs36055298 |
chr2:98545054-98545055 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs539654820 |
chr2:98545087-98545088 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs374335007 |
chr2:98545124-98545125 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs377663180 |
chr2:98545131-98545132 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs551735744 |
chr2:98545197-98545198 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs181218019 |
chr2:98545202-98545203 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs112979635 |
chr2:98545262-98545263 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs372269632 |
chr2:98545290-98545291 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs536177227 |
chr2:98545291-98545292 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs555772104 |
chr2:98545319-98545320 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs570292502 |
chr2:98545324-98545325 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs78379854 |
chr2:98545391-98545392 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs148788272 |
chr2:98545418-98545419 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs142469879 |
chr2:98545474-98545475 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs151288612 |
chr2:98545484-98545485 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs546036090 |
chr2:98545561-98545562 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs111647724 |
chr2:98545593-98545594 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs562644683 |
chr2:98545598-98545599 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs139364773 |
chr2:98545613-98545614 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs548497274 |
chr2:98545640-98545641 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs555543568 |
chr2:98545652-98545653 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs145601780 |
chr2:98545669-98545670 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs527285990 |
chr2:98545671-98545672 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs573856956 |
chr2:98545675-98545676 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs147791321 |
chr2:98545707-98545708 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs539121699 |
chr2:98545717-98545718 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs74506652 |
chr2:98545756-98545757 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs570266701 |
chr2:98545768-98545769 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs542634939 |
chr2:98545776-98545777 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs79740611 |
chr2:98545810-98545811 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs556069259 |
chr2:98545812-98545813 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs956696 |
chr2:98545841-98545842 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
40 |
rs535024474 |
chr2:98545848-98545849 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs558147681 |
chr2:98545849-98545850 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs185875319 |
chr2:98545865-98545866 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs75919948 |
chr2:98545904-98545905 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs576226558 |
chr2:98545914-98545915 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs190247312 |
chr2:98545915-98545916 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs370495328 |
chr2:98545955-98545956 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs182375517 |
chr2:98546032-98546033 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs527557369 |
chr2:98546080-98546081 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs547013335 |
chr2:98546098-98546099 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs563770760 |
chr2:98546130-98546131 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|